Skip to main content

Table 2 Demographics of study populations

From: The effect of age on CD4+ T-cell recovery in HIV-suppressed adult participants: a sub-study from AIDS Clinical Trial Group (ACTG) A5321 and the Bone Loss and Immune Reconstitution (BLIR) study

Baseline characteristics ACTG cohort (n = 102) BLIR study cohort (n = 20) Total (n = 122)
Age (years) 39 (18 – 64) 37 (30 – 51) 39 (18 – 64)
Sex Female 21 (21%) 3 (15%) 24 (20%)
Male 81 (79%) 17 (85%) 98 (80%)
Race Caucasian Non-Hispanic 51 (50%) 5 (25%) 56 (46%)
African American Non-Hispanic 19 (19%) 14 (70%) 33 (27%)
Hispanic 30 (29%) 1 (5%) 31 (25%)
Other 2 (2%) 0 2 (2%)
BMI 25.7 (18.6 – 47.2) 23.3 (18.9 – 35.5) 25.4 (18.6 – 47.2)
Prior Smoking History Yes 52 (51%) 16 (80%) 68 (56%)
No 50 (49%) 4 (20%) 54 (44%)
CD4+ T-cells (cells/mm3) 288 (8 – 980) 72.5 (3 – 268) 256 (3 – 980)
Viral load (log10RNA copies/mL) 4.61 (2.28 – 5.99) 5.3 (2.15 – 6.14) 4.67 (2.15 – 6.14)
ART Regimen NNRTI + NRTI 42 (41%) 0 42 (34)
PI + NRTI 39 (38%) 20 (100%) 59 (48%)
RAL + NRTI 19 (19%) 0 19 (16%)
Other 2 (2%) 0 2 (2)
HBV Infection Positive 1 (1%) No data No data
Negative 101 (99%) No data No data
HCV Infection Positive 3 (3%) No data No data
Negative 99 (97%) No data No data
  1. Continuous variables are presented as median (range). Categorical variables are presented as count (percentage)
  2. ACTG AIDS Clinical Trials Group, BLIR Bone Loss and Immune Reconstitution, BMI body mass index, HBV hepatitis B virus, HCV hepatitis C virus